CASI Pharmaceuticals, Inc. 4
4 · CASI Pharmaceuticals, Inc. · Filed Apr 8, 2015
Insider Transaction Report
Form 4
CAPITELLI SARA B
VP, Finance and PAO
Transactions
- Award
Stock Options (Right to Buy)
2015-04-06+65,000→ 65,000 totalExercise: $1.41Exp: 2025-04-06→ Common Stock (65,000 underlying)
Footnotes (1)
- [F1]The stock options vest as follows: 25% on the date of grant, and the remainder ratably over three years on a monthly basis.